Interim analysis from the TX45 Phase 1b Part A trial demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension ...

Primary endpoint met in Phase 2b trial with GH001 in TRD demonstrating -15.5 Point placebo-adjusted MADRS reductionFull response to the IND hold on track for submission in mid-2025Cash, cash equivalen ...

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its ...

MSFT's intensified R&D efforts and higher AI related capex have delivered higher adoption of its well diversified consumer/ ...

Global wariness of Chinese solar and E.V. domination offers India an opening. The government is spending money to try to ...

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results ...

Following announcement of prioritized development strategy for evorpacept in combination with anti-cancer antibodies at R&D Day in March, Company is on track to initiate Phase 2 ASPEN-Breast and Phase ...

Meta Platforms, Inc. has a strong ROI, market dominance, and untapped monetization. Click here to read an analysis of META ...

The CEO of Tether, Paolo Ardoino, unveiled the company’s new project, Tether (.)ai, at Consensus 2025. According to ...

The Proof of Capability program will provide businesses ... sparking fresh scrutiny of Berkshire’s leadership, cash buildup, and share valuation. We sell different types of products and services ...

Chumba is a veteran among sweepstakes casinos with one of the industry's most recognizable brands. You'll find a wide array ...